Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Stem Cell Research

  Free Subscription

Articles published in Transfusion

Retrieve available abstracts of 88 articles:
HTML format

Single Articles

    April 2021
    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:1007-1009.

    March 2021
  2. RENNERT W, Sobh L, Cormier K, Smith J, et al
    The impact of donor total estimated blood volume on nucleated cell yield in bone marrow harvests for hematopoietic stem cell transplantation.
    Transfusion. 2021 Mar 25. doi: 10.1111/trf.16374.
    PubMed     Abstract available

  3. GASIOR M, Ferreras C, de Paz R, Bueno D, et al
    The role of early natural killer cell adoptive infusion before engraftment in protecting against human herpesvirus-6B encephalitis after naive T-cell-depleted allogeneic stem cell transplantation.
    Transfusion. 2021 Mar 13. doi: 10.1111/trf.16354.
    PubMed     Abstract available

  4. CUZZUBBO D, Pegoraro F, Frenos S, Casini T, et al
    Planned haematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukaemia and persistent SARS-CoV-2 infection.
    Transfusion. 2021 Mar 8. doi: 10.1111/trf.16361.

    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:665-668.

    February 2021
  6. BELISARIO AR, da Costa Funes AP, Luz JR, de Almeida Costa L, et al
    Influence of laboratory procedures on postthawing cell viability and hematopoietic engraftment after autologous peripheral blood stem cell transplantation.
    Transfusion. 2021 Feb 10. doi: 10.1111/trf.16289.
    PubMed     Abstract available

  7. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    PubMed     Abstract available

    January 2021
  8. BHUNIA N, Abu-Arja R, Stanek JR, Shaw PJ, et al
    A multicenter report on the safety and efficacy of plerixafor based stem cell mobilization in children with malignant disorders.
    Transfusion. 2021 Jan 21. doi: 10.1111/trf.16260.
    PubMed     Abstract available

  9. KHAN J, Dunbar NM
    Time to stop worrying about ABO incompatible cryoprecipitate transfusions in adults.
    Transfusion. 2021;61:1-4.

    December 2020
  10. LI EW, Lee A, Vaseghi-Shanjani M, Anagnostopoulos A, et al
    Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most-needed donors.
    Transfusion. 2020 Dec 2. doi: 10.1111/trf.16186.
    PubMed     Abstract available

    November 2020
  11. PARTANEN A, Turunen A, Valtola J, Pyorala M, et al
    Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study.
    Transfusion. 2020 Nov 27. doi: 10.1111/trf.16198.
    PubMed     Abstract available

    October 2020
  12. ENOK BONONG PR, Buteau C, Delage G, Tanner JE, et al
    Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study).
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16149.
    PubMed     Abstract available

  13. MONAGHAN M, Yi QL, Green M, Campbell T, et al
    Factors associated with registrant availability for unrelated adult donor hematopoietic stem cell donation: Analysis of the stem cell registry at Canadian Blood Services.
    Transfusion. 2020 Oct 21. doi: 10.1111/trf.16129.
    PubMed     Abstract available

  14. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    PubMed     Abstract available

    September 2020
  15. NIZZI F, Rees M, Salzberg D, Ngwube A, et al
    Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange.
    Transfusion. 2020 Sep 5. doi: 10.1111/trf.16064.
    PubMed     Abstract available

    August 2020
  16. RHEAUME ME, Rouleau P, Tremblay T, Pare I, et al
    Short-Term exposure of umbilical cord blood CD34+ cells to human platelet lysate and cytokines enhances engraftment.
    Transfusion. 2020 Aug 5. doi: 10.1111/trf.15991.
    PubMed     Abstract available

    June 2020
  17. MARINELLI BUSILACCHI E, Costantini A, Mancini G, Bencivenga R, et al
    A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation.
    Transfusion. 2020 Jun 2. doi: 10.1111/trf.15825.
    PubMed     Abstract available

  18. ZHUANG L, Boriboonnangkul P, Wang S, Yuan S, et al
    Third time's a charm? Mobilization of autologous peripheral blood stem cells in patients with two previous failed mobilizations with plerixafor.
    Transfusion. 2020 Jun 1. doi: 10.1111/trf.15853.
    PubMed     Abstract available

    May 2020
  19. IKEDA K, Ohto H, Yamada-Fujiwara M, Okuyama Y, et al
    Hematopoietic cell infusion-related adverse events in pediatric/small recipients in a prospective/multicenter study.
    Transfusion. 2020;60:1015-1023.
    PubMed     Abstract available

    April 2020
  20. TURUNEN A, Partanen A, Valtola J, Ropponen A, et al
    CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkin's lymphoma patients: results of the prospective multicenter Goa study.
    Transfusion. 2020 Apr 24. doi: 10.1111/trf.15820.
    PubMed     Abstract available

  21. LEITNER GC, Ho M, Tolios A, Hopfinger G, et al
    The assessment of platelet function by thromboelastometry as a point-of-care test to guide Intercept-treated platelet support in hemato-oncological patients and hematopoietic stem cell transplantation recipients.
    Transfusion. 2020 Apr 22. doi: 10.1111/trf.15783.
    PubMed     Abstract available

    March 2020
  22. JAHAN S, Adam MK, Manesia JK, Doxtator E, et al
    Inhibition of ice recrystallization during cryopreservation of cord blood grafts improves platelet engraftment.
    Transfusion. 2020 Mar 18. doi: 10.1111/trf.15759.
    PubMed     Abstract available

    February 2020
  23. ROTH H, Schneider L, Eberle R, Lausen J, et al
    Zika virus infection studies with CD34(+) hematopoietic and megakaryocyte-erythroid progenitors, red blood cells and platelets.
    Transfusion. 2020 Feb 22. doi: 10.1111/trf.15692.
    PubMed     Abstract available

  24. CID J, Castillo C, Marin P, Carbasse G, et al
    Increased collection efficiency of CD34+ cells after mobilization with preemptive use of plerixafor followed by leukocytapheresis on the same day.
    Transfusion. 2020 Feb 17. doi: 10.1111/trf.15711.
    PubMed     Abstract available

  25. YUAN S, Zhuang L, Stinson S, Barton P, et al
    Red cell clumping in stem cell collection bag.
    Transfusion. 2020 Feb 16. doi: 10.1111/trf.15719.

  26. LIAO G, Gilmore K, Steed A, Elmoazzen H, et al
    Willingness of volunteers from Canadian Blood Service's Stem Cell Registry to donate blood, marrow, and other tissues for regenerative therapy.
    Transfusion. 2020 Feb 10. doi: 10.1111/trf.15695.
    PubMed     Abstract available

    January 2020
  27. SEIKE K, Fujii N, Asano N, Ohkuma S, et al
    Efficacy of HLA virtual cross-matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation.
    Transfusion. 2020 Jan 22. doi: 10.1111/trf.15664.
    PubMed     Abstract available

  28. AFZAL A, Tarbunova M, Despotis G, Grossman BJ, et al
    The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD).
    Transfusion. 2020 Jan 9. doi: 10.1111/trf.15653.
    PubMed     Abstract available

  29. HUSSEIN E, DeFor T, Wagner JE, Sumstad D, et al
    Evaluation of post-thaw CFU-GM: clinical utility and role in quality assessment of umbilical cord blood in patients receiving single unit transplant.
    Transfusion. 2020;60:144-154.
    PubMed     Abstract available

  30. YOON EJ, Zhang J, Weinberg RS, Brochstein JA, et al
    Validation of simple prediction algorithms to consistently achieve CD3+ and postselection CD34+ targets with leukapheresis.
    Transfusion. 2020;60:133-143.
    PubMed     Abstract available

    October 2019
  31. VELIER M, Granata A, Bramanti S, Calmels B, et al
    A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
    Transfusion. 2019 Oct 18. doi: 10.1111/trf.15545.
    PubMed     Abstract available

  32. YUAN S, Yang D, Nakamura R, Zhuang L, et al
    RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation.
    Transfusion. 2019 Oct 10. doi: 10.1111/trf.15531.
    PubMed     Abstract available

    September 2019
  33. TAJIMA K, Takizawa K, Yasuda T, Tsumanuma R, et al
    Characterization of reemergent anti-B red blood cell antibodies in a patient with recurrent acute myeloid leukemia with ABO-incompatible allogeneic peripheral blood stem cell transplantation.
    Transfusion. 2019 Sep 10. doi: 10.1111/trf.15510.
    PubMed     Abstract available

    July 2019
  34. BHOWMICK T, Rasool A, Desai A, Weinstein MP, et al
    Erythema migrans spares rash of engraftment syndrome.
    Transfusion. 2019;59:2193-2194.

    June 2019
  35. WARNER MA, Jambhekar NS, Saadeh S, Jacob EK, et al
    Implementation of a patient blood management program in hematopoietic stem cell transplantation.
    Transfusion. 2019 Jun 20. doi: 10.1111/trf.15414.
    PubMed     Abstract available

    May 2019
  36. CID J, Carbasse G, Suarez-Lledo M, Moreno DF, et al
    Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host disease.
    Transfusion. 2019 May 28. doi: 10.1111/trf.15384.
    PubMed     Abstract available

  37. AKEL S, Murray C, Ferguson W, Babic A, et al
    Outcomes of processing of bone marrow harvests for hematopoietic stem cell transplantation in pediatric patients utilizing a novel red blood cell sedimentation kit.
    Transfusion. 2019 May 8. doi: 10.1111/trf.15337.
    PubMed     Abstract available

  38. LAMARCHE MC, Hammond DE, Hopman WM, Sirosky-Yanyk A, et al
    Can we transfuse wisely in patients undergoing chemotherapy for acute leukemia or autologous stem cell transplantation?
    Transfusion. 2019 May 6. doi: 10.1111/trf.15335.
    PubMed     Abstract available

    April 2019
  39. GASTECKI K, Shanley R, Welbig J, Cohn C, et al
    Red blood cell product utilization in patients undergoing allogeneic stem cell transplantation.
    Transfusion. 2019 Apr 8. doi: 10.1111/trf.15285.
    PubMed     Abstract available

  40. CHRISTY BA, Herzig MC, Delavan C, Cantu C, et al
    Human primary fibroblasts perform similarly to MSCs in assays used to evaluate MSC safety and potency.
    Transfusion. 2019;59.
    PubMed     Abstract available

    March 2019
  41. KANG J, Hong JY, Yoon DH, Kim JE, et al
    Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis.
    Transfusion. 2019 Mar 29. doi: 10.1111/trf.15265.
    PubMed     Abstract available

  42. VIAU S, Eap S, Chabrand L, Lagrange A, et al
    Viral inactivation of human platelet lysate by gamma irradiation preserves its optimal efficiency in the expansion of human bone marrow mesenchymal stromal cells.
    Transfusion. 2019;59:1069-1079.
    PubMed     Abstract available

    February 2019
  43. JONES RE, Foster DS, Hu MS, Longaker MT, et al
    Wound healing and fibrosis: current stem cell therapies.
    Transfusion. 2019;59.
    PubMed     Abstract available

  44. FIERRO FA, Magner N, Beegle J, Dahlenburg H, et al
    Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions.
    Transfusion. 2019;59.
    PubMed     Abstract available

  45. HUPPERT LA, Liu KD, Matthay MA
    Therapeutic potential of mesenchymal stromal cells in the treatment of ARDS.
    Transfusion. 2019;59.

  46. GODBEY EA, Dormesy S, Gowda L, Nandi V, et al
    A dual strategy to optimize hematopoietic progenitor cell collections: validation of a simple prediction algorithm and use of collect flow rates guided by mononuclear cell count.
    Transfusion. 2019;59:659-670.
    PubMed     Abstract available

    January 2019
  47. DOBERSCHUETZ N, Soerensen J, Bonig H, Willasch A, et al
    Mobilized peripheral blood stem cell apheresis via Hickman catheter in pediatric patients.
    Transfusion. 2019 Jan 4. doi: 10.1111/trf.15113.
    PubMed     Abstract available

    A monthly roundup of key articles in other journals.
    Transfusion. 2019;59:12-14.

    December 2018
  49. ONO Y, Yoshioka S, Inoue K, Yoshida M, et al
    Stochastic model based on preharvest peripheral CD34-positive cell count and collection efficiency predicting processed blood volume in peripheral hematopoietic stem cell apheresis.
    Transfusion. 2018 Dec 28. doi: 10.1111/trf.15096.
    PubMed     Abstract available

  50. ROHNER N, Passweg JR, Tsakiris DA, Halter JP, et al
    The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantation.
    Transfusion. 2018 Dec 17. doi: 10.1111/trf.15107.
    PubMed     Abstract available

  51. DE GREEF GE, Braakman E, van der Holt B, Janssen JJWM, et al
    The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA-identical sibling donors: results of the HOVON-107 study.
    Transfusion. 2018 Dec 11. doi: 10.1111/trf.15037.
    PubMed     Abstract available

  52. GALEL D, Crisostomo C, Ortega J, Peters K, et al
    Nucleated red blood cells as a novel indicator of CD34(+) cell content in umbilical cord blood.
    Transfusion. 2018 Dec 7. doi: 10.1111/trf.15080.
    PubMed     Abstract available

  53. MUNIZ ALERS SM, Page K, Simmons R, Waters-Pick B, et al
    Automated thawing increases recovery of colony-forming units from banked cord blood unit grafts.
    Transfusion. 2018;58:2911-2917.
    PubMed     Abstract available

    November 2018
  54. QUEK J, Lee JJ, Lim FL, Diong C, et al
    Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.
    Transfusion. 2018 Nov 22. doi: 10.1111/trf.15053.
    PubMed     Abstract available

  55. PARTANEN A, Valtola J, Ropponen A, Kuitunen H, et al
    Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34(+) cells in non-Hodgkin lymphoma patients.
    Transfusion. 2018 Nov 19. doi: 10.1111/trf.14993.
    PubMed     Abstract available

  56. LEE JH, Park J, Lee JW
    Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury.
    Transfusion. 2018 Nov 1. doi: 10.1111/trf.14838.
    PubMed     Abstract available

  57. CHOU ST
    "Rare" reagent red cells: rare no longer?
    Transfusion. 2018;58:2469-2471.

  58. KIKUCHI G, Kurita R, Ogasawara K, Isa K, et al
    Application of immortalized human erythroid progenitor cell line in serologic tests to detect red blood cell alloantibodies.
    Transfusion. 2018;58:2675-2682.
    PubMed     Abstract available

    October 2018
  59. GRIFFITH LM, VanRaden M, Barrett AJ, Childs RW, et al
    Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993-2010): factors that predict intensity and time to transfusion independence.
    Transfusion. 2018 Oct 26. doi: 10.1111/trf.14966.
    PubMed     Abstract available

  60. VERDU-AMOROS J, Woessmann W, Maecker-Kolhoff B, Schulz A, et al
    Mini photopheresis for refractory chronic graft-versus-host disease in children and adolescents.
    Transfusion. 2018 Oct 6. doi: 10.1111/trf.14880.
    PubMed     Abstract available

    September 2018
  61. IEMURA T, Itoh M, Mano C, Oba A, et al
    Successful engraftment after cord blood transplantation from an HLA-homozygous donor (homo-to-hetero cord blood transplantation) in a primary myelofibrosis patient with broad HLA antibodies.
    Transfusion. 2018 Sep 28. doi: 10.1111/trf.14885.
    PubMed     Abstract available

  62. KLEINMAN S, Stassinopoulos A
    Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Transfusion. 2018 Sep 28. doi: 10.1111/trf.14930.
    PubMed     Abstract available

  63. INIESTA P, Revilla N, Chen-Liang TH, Hurtado AM, et al
    An early increase of CD56(bright) natural killer subset as dominant effect and predictor of response to extracorporeal photopheresis for graft-versus-host disease.
    Transfusion. 2018 Sep 27. doi: 10.1111/trf.14964.
    PubMed     Abstract available

  64. ARLT N, Rothe R, Sielaff S, Juretzek T, et al
    Sterility release testing of peripheral blood stem cells for transplantation: impact of culture bottles and incubation temperature.
    Transfusion. 2018 Sep 27. doi: 10.1111/trf.14910.
    PubMed     Abstract available

  65. RUSSELL AL, Lefavor RC, Zubair AC
    Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications.
    Transfusion. 2018 Sep 10. doi: 10.1111/trf.14805.
    PubMed     Abstract available

  66. ALVA LC, Bacher U, Seipel K, Mansouri Taleghani B, et al
    Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia.
    Transfusion. 2018 Sep 10. doi: 10.1111/trf.14895.
    PubMed     Abstract available

  67. HESS J, Su L, Nizzi F, Beebe K, et al
    Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept.
    Transfusion. 2018 Sep 4. doi: 10.1111/trf.14907.
    PubMed     Abstract available

  68. TAKANASHI M, Selogie E, Reems JA, Stroncek D, et al
    Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
    Transfusion. 2018;58:2184-2191.
    PubMed     Abstract available

    July 2018
  69. SPOERL S, Wascher D, Nagel S, Peschel C, et al
    Evaluation of the new continuous mononuclear cell collection protocol versus an older version on two different apheresis machines.
    Transfusion. 2018;58:1772-1780.
    PubMed     Abstract available

    May 2018
  70. AHN H, Tay J, Shea B, Hutton B, et al
    Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysis.
    Transfusion. 2018 May 16. doi: 10.1111/trf.14656.
    PubMed     Abstract available

  71. SIEGEL G, Fleck E, Elser S, Hermanutz-Klein U, et al
    Manufacture of endothelial colony-forming progenitor cells from steady-state peripheral blood leukapheresis using pooled human platelet lysate.
    Transfusion. 2018;58:1132-1142.
    PubMed     Abstract available

    April 2018
  72. NIITTYVUOPIO R, Juvonen E, Heiskanen J, Lindstrom V, et al
    Extracorporeal photopheresis in the treatment of acute graft-versus-host disease: a single-center experience.
    Transfusion. 2018 Apr 29. doi: 10.1111/trf.14649.
    PubMed     Abstract available

  73. MINAKAWA K, Ohto H, Yasuda H, Saito S, et al
    Efficacy of D- red blood cell transfusion and rituximab therapy in autoimmune hemolytic anemia with anti-D and panreactive autoantibodies arising after hematopoietic stem cell transplant.
    Transfusion. 2018 Apr 17. doi: 10.1111/trf.14634.
    PubMed     Abstract available

  74. CASTRO G, Merkel PA, Giclas HE, Gibula A, et al
    Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.
    Transfusion. 2018 Apr 2. doi: 10.1111/trf.14589.
    PubMed     Abstract available

    March 2018
  75. RUSSELL AL, Lefavor R, Durand N, Glover L, et al
    Modifiers of mesenchymal stem cell quantity and quality.
    Transfusion. 2018 Mar 26. doi: 10.1111/trf.14597.
    PubMed     Abstract available

  76. BOJANIC I, Mravak Stipetic M, Pulanic D, Desnica L, et al
    Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease.
    Transfusion. 2018 Mar 14. doi: 10.1111/trf.14594.
    PubMed     Abstract available

  77. WANG T, Remberger M, Axdorph Nygell U, Sundin M, et al
    Change of apheresis device decreased the incidence of severe acute graft-versus-host disease among patients after allogeneic stem cell transplantation with sibling donors.
    Transfusion. 2018 Mar 13. doi: 10.1111/trf.14579.
    PubMed     Abstract available

    February 2018
  78. MARCHESI F, Vacca M, Giannarelli D, Ipsevich F, et al
    Lenograstim 5 microg/kg is not superior to biosimilar filgrastim 10 microg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14533.
    PubMed     Abstract available

  79. WOREL N, Lehner E, Fuhrer H, Kalhs P, et al
    Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14506.
    PubMed     Abstract available

  80. REICH-SLOTKY R, Cushing MM, Hsu YS, Ancharski M, et al
    Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.
    Transfusion. 2018;58:339-344.
    PubMed     Abstract available

  81. PARK G, Shayani S, Stiller T, Wang S, et al
    Dose capping of plerixafor in patients weighing more than 100 kg at one vial led to successful mobilization outcomes and significant cost savings.
    Transfusion. 2018;58:323-329.
    PubMed     Abstract available

    December 2017
  82. ZHU J, Huang H, Chen H, Zhang X, et al
    Plerixafor and granulocyte-colony-stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non-Hodgkin's lymphoma: a randomized Phase 3 study.
    Transfusion. 2017 Dec 13. doi: 10.1111/trf.14426.
    PubMed     Abstract available

  83. VILLA CH, Porturas T, Sell M, Wall M, et al
    Rapid prediction of stem cell mobilization using volume and conductivity data from automated hematology analyzers.
    Transfusion. 2017 Dec 11. doi: 10.1111/trf.14449.
    PubMed     Abstract available

  84. PIERCE J, Benedetti E, Preslar A, Jacobson P, et al
    Comparative analyses of industrial-scale human platelet lysate preparations.
    Transfusion. 2017;57:2858-2869.
    PubMed     Abstract available

    November 2017
  85. PIERELLI L, Bosi A, Olivieri A
    "Best practice" for extracorporeal photopheresis in acute and chronic graft-versus-host disease by Societa' Italiana di Emaferesi and Manipolazione Cellulare and Gruppo Italiano Trapianto Midollo Osseo: a national survey to ascertain its degree of app
    Transfusion. 2017 Nov 13. doi: 10.1111/trf.14400.
    PubMed     Abstract available

  86. SOURI M, Nikougoftar Zarif M, Rasouli M, Golzadeh K, et al
    Comparison of human umbilical cord blood processing with or without hydroxyethyl starch.
    Transfusion. 2017;57:2758-2766.
    PubMed     Abstract available

    September 2017
  87. FINGRUT W, Parmar S, Cuperfain A, Rikhraj K, et al
    The Stem Cell Club: a model for unrelated stem cell donor recruitment.
    Transfusion. 2017 Sep 24. doi: 10.1111/trf.14327.
    PubMed     Abstract available

    July 2017
  88. ALBANO MS, Ciubotariu R, Dobrila L, Tarnawski M, et al
    Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency.
    Transfusion. 2017 Jul 31. doi: 10.1111/trf.14257.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.